Filtros de búsqueda

Lista de obras de

Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).

artículo científico publicado en 2008

Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease

artículo científico publicado en 2009

Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study

artículo científico publicado en 2010

Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis

article

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

artículo científico publicado en 2007

Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue

artículo científico publicado en 2007

Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease

artículo científico publicado en 2009

Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model

artículo científico publicado en 2009

Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).

artículo científico publicado en 2008

Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation

artículo científico publicado en 2009

Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats

artículo científico publicado en 2007

Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage

artículo científico publicado en 2007